World leading researchers collaborate for Alzheimer's study

CSIRO has brought together world experts in a major study to investigate Alzheimer’s disease.

Biobank to aid disease prediction and diagnosis

A 'biobank' of blood samples from healthy elderly Australians will aid research in the prediction and early diagnosis of diseases such as Alzheimer’s and cancer.

Cohort study of stroke

Substantially reducing the millions of cases of stroke recorded worldwide every year is the focus of this collaborative CSIRO research cluster.

Biomarkers to nip bowel cancer in the bud

Finding biomarkers for earliest-stage colorectal cancer will help to lower mortality rates in individuals at risk of developing this disease.

Early cancer screening saves lives

Together with collaborators, the Flagship aims to better understand peoples’ risk perception and intention to undertake screening for bowel cancer

Focussing on Australia's second biggest killer

Substantially reducing the millions of cases of stroke recorded worldwide every year is the focus of a new collaborative CSIRO research 'cluster' being launched in Melbourne today.

Putting Alzheimer’s on early notice

Australian scientists have presented key findings at an international Alzheimer’s disease conference this week. Their major focus is on early detection and discovering why the disease progresses.

Uncovering early stages of Alzheimer’s Disease

A major Australian study has provided new insights into the loss of structure in regions of the brain and its potential association with Alzheimer’s Disease.

Advance in bowel cancer test research

Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Bioprospecting drives the search for foods with proven health benefits

Food Futures assays used to produce and identify new bioactives present in foods that have proven health benefits.
Current tests screen against risk-factors and biomarkers for coronary heart disease (cholesterol production and uptake, and blood pressure), colorectal cancer and inflammatory diseases. The challenge is identifying novel bioactives that may reduce the incidence of chronic disease.

Microencapsulating bioactives for food and pharmaceuticals

Developments in microencapsulation technology are creating new applications and opportunities in the food and pharmaceutical industries.

Microscope solution for counting bacteria

Preventative Health Flagship researchers have developed an integrated microscope system to automatically count bacteria in human faeces.

Starplus™ starch for healthier bowels

CSIRO’s Starplus™ technology incorporates natural starch from cereals into foods or dietary supplements to improve bowel health and colon function.  
Starplus™ is a new technology for delivering optimal concentrations of short chain fatty acids (SCFA), in starch-based products, to the colon. Increasing levels of these acids is likely to have significant preventative and therapeutic effects on gastrointestinal diseases.  

Alzheimer’s protein puts top brains to the test

CSIRO scientists and collaborators have made major inroads in cracking a structure of the protein thought to cause Alzheimer’s disease.

Gaming technology to make colonoscopies safer

CSIRO is using the latest in computer gaming technology to help reduce the incidence of one of the most common cancers in Australia – bowel cancer.

Professor Lynne Cobiac: Director, Preventative Health Flagship

Professor Lynne Cobiac leads CSIRO’s Preventative Health Flagship in delivering scientific outcomes that have a positive impact on the Australian community.

Dr Trevor Lockett: leading colorectal cancer research

Dr Lockett is responsible for the strategic development, science planning and project portfolio management of colorectal (bowel) cancer research.

Dr Lance Macaulay: leading neurodegenerative diseases research

Focusing on brain health, age onset disease and preventing dementia.